hyperthyroidism and glp 1 Glucagon-like peptide receptor agonist use risk of thyroid cancer: Scandinavian cohort study Hepatic thyroid hormone signalling modulates

Conclusions Data gleaned over the last few years have allowed the unmasking of some of the mechanisms exerted by GLP-1 and/or its longer acting agonists in energy and metabolic homeostasis

Both medications influence your body's energy utilization and glucose handling

Clinical trials demonstrate a clear dose-response relationship, with higher doses producing greater HbA1c reductions and weight loss

Debska-VielhaberGMininIKudinAet al

The following history attempts to correct the traditional narrative by capturing some of the women's voices and the many different roles they played alongside male colleagues in shaping the development of GLP-1 drugs